Modelo abierto de dos compartimentos: administración extravascular

A two-compartment extravascular model features a central compartment where the drug is first absorbed and a peripheral compartment that illustrates drug distribution throughout the body. The central compartment receives the drug after absorption, while the peripheral compartment represents tissues where the drug distributes. Together, these compartments describe how drugs move through the body after oral or other non-intravenous administration.

The absorption exponent (ka) indicates how quickly the drug is absorbed into the central compartment. The distribution exponent describes how the drug disperses from the central to peripheral compartment. The elimination exponent accounts for drug removal from the body. Together, these three factors determine the rate of change in drug concentration over time and can be resolved using the method of residuals.

The method of residuals can estimate the absorption exponent and other pharmacokinetic parameters when the absorption rate constant (ka) is significantly larger than the distribution and elimination exponents. This condition ensures that the absorption phase is distinct and can be accurately separated from later phases, allowing reliable parameter estimation from plasma concentration-time data.

The Loo-Riegelman method requires plasma drug concentration-time data collected after both oral and intravenous administration of the same drug to the same subject at different times. This method can estimate ka for drugs exhibiting two-compartment characteristics and can be applied to drugs distributed in any number of compartments, making it more versatile than the Wagner-Nelson method.

The Loo-Riegelman method is used for drugs with two-compartment characteristics and can be applied to drugs distributed in any number of compartments. The Wagner-Nelson method is typically used for drugs with one-compartment characteristics. Both methods require plasma concentration data from oral and intravenous administration, but the Loo-Riegelman method offers greater flexibility for complex distribution patterns.

First-order absorption describes how a drug enters the body via a process where the absorption rate depends on the drug concentration at the absorption site. This process is fundamental to the two-compartment extravascular model equation, which measures drug concentration change over time. Understanding first-order absorption is essential for accurately predicting drug behavior and optimizing dosing regimens.

The central compartment is where the drug is first absorbed after extravascular administration and serves as the primary site for measuring plasma drug concentration. From the central compartment, the drug distributes to the peripheral compartment and is simultaneously eliminated. The rate of change in central compartment concentration is calculated using the absorption, distribution, and elimination exponents.